Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%

On May 15, 2026, Madison Avenue Partners disclosed a new position in Indivior (NASDAQ:INDV), acquiring 4,315,162 shares in the first quarter—an estimated $142.51 million trade based on quarterly average pricing.According to its SEC filing dated May 15, 2026, Madison Avenue Partners opened a new position in Indivior (NASDAQ:INDV) during the first quarter by acquiring 4,315,162 shares. The estimated value of the trade was $142.51 million, calculated using the mean unadjusted closing price over the quarter. At quarter’s end, the stake was valued at $131.53 million, reflecting both trading activity and price movements.Indivior is a specialty pharmaceutical company focused on addressing opioid dependence through proprietary buprenorphine-based therapies. The company leverages its expertise in addiction treatment and operates in the United States, Rest of World, and United Kingdom markets.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool